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Cardiovascular disease is the leading cause of death globally, despite advances in 35 risk stratification, diagnostic tools and preventative therapies (1). Consequently, 36 there remains major interest in refining our current methods of diagnosis and risk 37 stratification to better individualise preventative therapies. Myocardial infarction is 38 most commonly caused by rupture of atherosclerotic plaque. Plaques that are prone 39 to rupture have certain common characteristics that together define the vulnerable 40 plaque. Vulnerable plaques have played an integral role in our understanding of 41 atherosclerosis and cardiovascular disease, with extensive research conducted to 42 better characterise and identify these lesions (2). However, appreciation of the fact 43 that the majority of vulnerable plaques ruptures are clinically silent has led to a 44 paradigm shift in atherosclerotic plaque imaging; focus has shifted from the level of 45 the individual plaque to the patient (3), and from invasive to non-invasive imaging 46 modalities. This change has coincided with advances in non-invasive imaging 47
techniques which now facilitate comprehensive assessments of plaque 48 characteristics and disease activity across the coronary vasculature. Hybrid 49 cardiovascular imaging is at the frontier of clinical research in this field, although it 50 has yet to become adopted for routine clinical use. 51 52
HYBRID IMAGING: RATIONALE AND CONCEPTS 53
The pathophysiology of atherosclerosis and the vulnerable plaque is well-described 54
(2). There are hallmarks characteristics of high-risk plaque that have been identified 55 on histology, invasive intracoronary imaging and computed tomography coronary 56 angiography (CTCA) which serve as specific targets for hybrid coronary imaging. 57
The prototypical thin-cap fibroatheroma features inflammation (predominantly M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 4 macrophage infiltration), a large lipid-rich necrotic core, a thin fibrous cap (<65 µm), 59 superficial microcalcification and plaque haemorrhage. Notably, these findings are 60 independent of stenosis severity; myocardial infarction is often due to plaque rupture 61 in non-obstructive lesions (4, 5). As our ability to image these plaques has improved 62 it has become clear that the majority of these lesions appear to either heal or rupture 63 sub-clinically with only very few leading to myocardial infarction. In the landmark 64 PROSPECT trial (4), 596 thin-cap fibroatheromas were identified on virtual-histology 65 intravascular ultrasound (IVUS) in a cohort of 697 patients with acute coronary 66 syndrome. After 3 years' follow-up, only 31 myocardial infarctions, cardiac arrests or 67 cardiac deaths occurred. Of these, 14 were related to the original culprit lesion. The 68
recent Lipid Rich Plaque study demonstrated that the lipid core burden index on 69 near-infrared spectroscopy IVUS predicted both culprit and non-culprit major adverse 70 cardiovascular events at 24 months (6). The value of invasive assessments of 71 plaque morphology and plaque-directed therapies has therefore been questioned. 72
Vulnerable plaque assessment appears to be of greater value at the level of the 73 patient, using non-invasive imaging to interrogate the entire coronary vasculature. 74
Those subjects in whom adverse plaque characteristics are identified are at 75 increased risk of future events, although the originally identified lesion may not itself 76 result in a clinical event. As such, total atherosclerotic burden has yet to be 77 superceded for prognostic purposes by any plaque-level imaging (3). 78 79 Hybrid imaging techniques combine two different modalities, taking advantage of 80 their individual strengths to provide a comprehensive dataset. A modality with high 81 temporal and spatial resolution is required to provide anatomical detail and 82 assessments of soft tissue composition. For the coronary arteries, the most common
of these is CTCA, although cardiovascular magnetic resonance (CMR) can also be 84 utilised. For hybrid coronary plaque assessment, this dataset is most commonly 85 fused with positron emission tomography (PET). This allows interrogation of plaque 86 biology and potentially any disease process but requires appropriately targeted 87 radiotracers. The ability of hybrid PET-CT and PET-MR to provide this breadth of 88 information about anatomy, plaque composition and disease activity make them 89
exciting techniques with which to study coronary atherosclerosis. 90
91

HYBRID IMAGING: PLAQUE CHARACTERISTICS 92
Non-invasive imaging of vulnerable plaque morphology has been extensively studied 93 with CT and MR as described below. isotopes. An understanding of plaque biology and the various components of 160 vulnerable plaque are critical to determine suitable targets for molecular imaging. 161
PET has been studied for many years, primarily in other specialties such as 162 oncology. Coronary PET imaging has previously been limited due to poor spatial 163 resolution, partial volume effects and cardiac motion. However, with improvements in 164 scanners and the development of advanced motion correction and co-registration 165 techniques, many of these limitations have been overcome. There is now major 166 research interest in coronary PET imaging for the assessment of disease activity 167 within atherosclerotic plaques. This interest had led to the advent of bespoke tracers 168 targeting specific aspects of plaque biology to complement the use of more 169 established radiotracers that have been re-purposed from other fields. repeatability (33). This improved ability to detect discrete coronary artery uptake 209 compared to 18F-FDG appears to be due to low 18F-NaF uptake in the adjacent 210 myocardium and very high affinity of the tracer for microcalcification (30, 34) Again, 211
18F-NaF appears to be providing different information to the presence of calcium on 212 CT; in one study, almost a half of patients with a calcium score >1000 Agatston 213 units did not have any coronary 18F-NaF uptake (33). In keeping with the hypothesis 214 that 18F-NaF uptake is associated with vulnerable plaque, several clinical studies 215 have demonstrated uptake to be associated with culprit and high-risk coronary 216 plaque as defined by invasive angiography, intravascular ultrasound and CTCA. In 217 the first report, increased 18F-fluoride uptake was observed at the site of the culprit 218 coronary plaque in 37 of the 40 patients with recent myocardial infarction (29), a 219 finding supported by two subsequent smaller studies (35, 36) . (based on invasive FFR) (54). Although this study showed only limited additional 296 diagnostic value with hybrid imaging, a recent meta-analysis confirmed incremental 297 diagnostic performance with hybrid anatomy/perfusion imaging compared to CTCA 298 (55). Additionally, several retrospective studies consistently described an 299 incremental prognostic value of combining myocardial perfusion imaging and CTCA 300 (56, 57). Further data is now needed to investigate the association between adverse 301 plaque features and myocardial perfusion on PET, to assess whether the latter might 302 also provide a surrogate for unstable coronary plaque phenotypes. 303
304
The future of non-invasive coronary anatomy/physiology imaging is therefore 305 extremely promising; there is great appeal in deriving a hybrid dataset assessing M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
14 coronary anatomy, plaque morphology, plaque burden and coronary flow at both a 307 lesion and vessel level. Randomized clinical trials will be highly anticipated. 308
309
CURRENT LIMITATIONS 310
Although the appeal of hybrid imaging is clear, there remain some limitations. Most 311 crucially, until recently there has been a lack of randomised data demonstrating the 312 ability of these imaging techniques to change outcomes. We now have this data 313 supporting the use of CTCA, but there is a major need for similar data demonstrating 314 the benefits of hybrid non-invasive ischaemia testing. Furthermore, access to 315 scanners and integration of these imaging techniques into clinical workflows in 316 imaging departments must be considered. Costs is also an issue, particularly with 317 regards to the production of bespoke radiotracers for nuclear imaging. Consequently, 318 which test to use in which patients in what setting must be carefully considered, 319 taking into account all of these factors. This is in addition to other clinical factors that 320 may influence the choice of test, such as patient age, likelihood of calcific disease, 321 ability to achieve adequate heart rate control, comorbidities and acceptable radiation 322 Figure 1A) . Optical coherence tomography demonstrated plaque 332 rupture with red thrombus in the mid-vessel lesion and aggressive neointimal 333 hyperplasia in the proximal lesion ( Figure 1B-C) . Two drug-eluting stents were 334 implanted with a good angiographic result ( Figure 1D ). The left system, particularly 335 the left anterior descending artery (LAD), had diffuse plaque without obstructive 336 disease ( Figure 1E ). As part of a research study, the patient underwent 18F-NaF 337 PET-CT six weeks later. This demonstrated three discrete regions of focal uptake in 338 the proximal, mid and distal RCA (arrows). Although the mid-RCA lesion was the 339 culprit, the highest uptake was in the proximal restenotic lesion. In contrast to the 340 RCA, the diffusely diseased LAD had non-obstructive calcific plaque without high-341
risk features on CTCA and did not demonstrate any 18F-NaF uptake ( Figure 1F) . Figure 1A) . Extensive near-transmural infarction in this territory was seen on late 351 gadolinium enhancement ( Figure 1B) . Focal 18F-NaF uptake was noted in the culprit 352 lesion ( Figure 1C 
